OverviewSuggest Edit

Geron is a clinical-stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Telomerase is an enzyme that enables cancer cells, including malignant progenitor cells, to maintain telomere length, which provides them with the capacity for limitless, uncontrolled proliferation. Imetelstat is designed to be an oligonucleotide that targets and binds with high affinity to the active site of telomerase, thereby directly inhibiting telomerase activity and impeding malignant cell proliferation.

TypePublic
Founded1990
HQMenlo Park, US
Websitegeron.com
Employee Ratings2.8

Latest Updates

Employees (est.) (Dec 2018)17(+14%)
Revenue (FY, 2017)$1.1 M(-82%)
Share Price (Oct 2019)$1.5 (+7%)

Key People/Management at Geron

John A. Scarlett

John A. Scarlett

Chairman of the Board, President and Chief Executive Officer
Olivia K. Bloom

Olivia K. Bloom

Executive Vice President, Finance, Chief Financial Officer and Treasurer
Melissa A. Kelly Behrs

Melissa A. Kelly Behrs

Executive Vice President and Chief Business Officer
Andrew J. Grethlein

Andrew J. Grethlein

Executive Vice President and Chief Operating Officer
Aleksandra Rizo

Aleksandra Rizo

Executive Vice President and Chief Medical Officer
Stephen N. Rosenfield

Stephen N. Rosenfield

Executive Vice President, Chief Legal Officer and Corporate Secretary
Show more

Geron Office Locations

Geron has offices in Menlo Park and Canton
Menlo Park, US (HQ)
149 Commonwealth Dr
Canton, US
250 Royall St
Show all (2)

Geron Financials and Metrics

Geron Revenue

Geron's revenue was reported to be $1.07 m in FY, 2017
USD

Net income (FY, 2018)

(27.0m)

EBIT (FY, 2018)

(31.1m)

Market capitalization (11-Oct-2019)

288.3m

Closing stock price (11-Oct-2019)

1.5

Cash (31-Dec-2018)

10.6m
Geron's current market capitalization is $288.3 m.
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.3m36.4m6.2m1.1m

General and administrative expense

15.6m17.8m18.8m19.3m18.7m

R&D expense

23.2m17.8m18.0m11.0m13.4m

Operating expense total

40.2m36.9m36.8m30.3m32.1m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

35.4m5.1m

General and administrative expense

3.5m4.0m3.9m4.1m4.0m4.3m4.8m4.5m4.7m4.7m4.4m4.8m5.3m4.2m

R&D expense

5.3m5.2m5.2m6.0m4.8m4.1m5.0m4.6m4.3m3.4m2.5m2.6m2.4m3.2m

Operating expense total

8.9m9.2m9.0m10.1m8.8m8.3m9.8m9.1m9.0m8.0m6.9m7.4m7.8m7.5m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

13.0m42.8m21.2m12.8m16.3m10.6m

Accounts Receivable

1.1m

Inventories

Current Assets

67.1m153.4m115.9m116.1m96.0m166.1m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(38.4m)(35.7m)46.0k(29.5m)(27.9m)(27.0m)

Depreciation and Amortization

320.0k47.0k56.0k81.0k76.0k59.0k

Inventories

Accounts Payable

(2.0m)(364.0k)(873.0k)65.0k278.0k479.0k
Quarterly
USDQ3, 2013Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(29.1m)(9.4m)27.2m(8.8m)(8.6m)(3.6m)(7.2m)

Depreciation and Amortization

357.0k

Accounts Payable

1.2m2.4m1.2m957.0k574.0k396.0k235.0k271.0k308.0k

Cash From Operating Activities

(29.9m)
USDY, 2018

Financial Leverage

1 x
Show all financial metrics

Geron Online and Social Media Presence

Embed Graph

Geron News and Updates

Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes

MENLO PARK, Calif., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that the first patient has been dosed in the IMerge Phase 3 clinical trial to evaluate imetelstat, a first-in-class telomerase inhibitor, in lower risk myelodysplastic syndromes (MDS).

Geron Appoints Vice President, Human Resources

MENLO PARK, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the appointment of Shannon Odam as Vice President, Human Resources. Ms. Odam joins other recently recruited senior leadership to further strengthen the organization as it expands its operations t…

Geron to Webcast KOL Event on June 25, 2019

MENLO PARK, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that the Company will webcast an event on June 25, 2019, featuring key opinion leaders (KOLs) who are authors of imetelstat data presentations being made at the 24th Annual Congress of the Europe…

Geron Continues to Build Senior Leadership of Its Development Team

MENLO PARK, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it is continuing to build the senior leadership of its development team with the addition of a Vice President, Biometrics, and a Vice President, Manufacturing. Their oncology and drug develop…

Geron Corporation Reports First Quarter 2019 Financial Results

MENLO PARK, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the first quarter ended March 31, 2019. As of the quarter-end, the Company had approximately $170 million in cash and marketable securities, which is sufficient to support the…

Geron to Present at Needham Healthcare Conference

MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, is scheduled to present a company overview at the 18th Annual Needham Healthcare Conference in New York at 3:30 p.m. ET on Tues…
Show more

Geron Frequently Asked Questions

  • When was Geron founded?

    Geron was founded in 1990.

  • Who are Geron key executives?

    Geron's key executives are John A. Scarlett, Olivia K. Bloom and Melissa A. Kelly Behrs.

  • How many employees does Geron have?

    Geron has 17 employees.

  • Who are Geron competitors?

    Competitors of Geron include Aptevo Therapeutics, Aeglea Biotherapeutics and Cleveland BioLabs.

  • Where is Geron headquarters?

    Geron headquarters is located at 149 Commonwealth Dr, Menlo Park.

  • Where are Geron offices?

    Geron has offices in Menlo Park and Canton.

  • How many offices does Geron have?

    Geron has 2 offices.